Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib + Temozolomide in Metastatic Colorectal Cancer
NCT01051596Phase 2Completed
- Sponsor
- Georgetown University
- Start
- Sep 2009
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of veliparib in metastatic colorectal cancer (mCRC), sponsored by Georgetown University. Primary endpoint: Disease Control Rate at 2 months. Started Sep 2009; status: completed.
02
Drugs
veliparib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01051596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01051596.